CVS Drug Benefits Managment Growth Pace Pleases Analysts

By: via Benzinga
CVS Caremark's (NYSE: CVS) second-quarter performance in its prescription benefits management segment drew plaudits from analysts ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.